937
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

The role of machine learning in healthcare responses to pandemics: maximizing benefits and filling gaps

ORCID Icon, &
Pages 777-780 | Received 06 May 2023, Accepted 07 Jun 2023, Published online: 16 Jun 2023

References

  • Marziano V, Guzzetta G, Menegale F, et al. The decline of COVID-19 severity and lethality over two years of pandemic. medRxiv. Published Online 2022. doi: 10.1101/2022.07.01.22277137.
  • Di Fusco M, Shea KM, Lin J, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308–317. doi: 10.1080/13696998.2021.1886109.
  • van der Schaar M, Alaa AM, Floto A, et al. How artificial intelligence and machine learning can help healthcare systems respond to COVID-19. Mach Learn. 2021;110(1):1–14. doi: 10.1007/s10994-020-05928-x.
  • Wang L, Zhang Y, Wang D, et al. Artificial intelligence for COVID-19: a systematic review. Front Med. 2021;8:704256. doi: 10.3389/fmed.2021.704256.
  • Yan L, Zhang HT, Goncalves J, et al. A machine learning-based model for survival prediction in patients with severe COVID-19 infection. medRxiv. Published online 2020. doi: 10.1101/2020.02.27.20028027.
  • Al-Raeei M. The forecasting of COVID-19 with mortality using SIRD epidemic model for the United States, russia, China, and the Syrian Arab Republic. AIP Adv. 2020;10(6):065325. doi: 10.1063/5.0014275.
  • Chimmula VKR, Zhang L. Time series forecasting of COVID-19 transmission in Canada using LSTM networks. Chaos Solitons Fractals. 2020;135:109864. doi: 10.1016/j.chaos.2020.109864.
  • Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA. 2020;323(14):1341–1342. doi: 10.1001/jama.2020.3151.
  • Priya S, Tripathi G, Singh DB, et al. Machine learning approaches and their applications in drug discovery and design. Chem Biol Drug Des. 2022;100(1):136–153. doi: 10.1111/cbdd.14057.
  • Kimber TB, Chen Y, Volkamer A. Deep learning in virtual screening: recent applications and developments. IJMS. 2021;22(9):4435. doi: 10.3390/ijms22094435.
  • Gentile F, Agrawal V, Hsing M, et al. Deep docking: a deep learning platform for augmentation of structure based drug discovery. ACS Cent Sci. 2020;6(6):939–949. doi: 10.1021/acscentsci.0c00229.
  • Ton AT, Gentile F, Hsing M, et al. Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Mol Inform. 2020;39(8):e2000028. doi: 10.1002/minf.202000028.
  • Yang F, Zhang Q, Ji X, et al. Machine learning applications in drug repurposing. Interdiscip Sci. 2022;14(1):15–21. doi: 10.1007/s12539-021-00487-8.
  • Zeng X, Song X, Ma T, et al. Repurpose open data to discover therapeutics for COVID-19 using deep learning. J Proteome Res. 2020;19(11):4624–4636. doi: 10.1021/acs.jproteome.0c00316.
  • Char DS, Shah NH, Magnus D. Implementing machine learning in health care – addressing ethical challenges. N Engl J Med. 2018;378(11):981–983. doi: 10.1056/NEJMp1714229.
  • Nayyar A, Gadhavi L, Zaman N. Chapter 2 – Machine learning in healthcare: review, opportunities and challenges. In: Singh KK, Elhoseny M, Singh A, Elngar AA, eds. Machine learning and the internet of medical things in healthcare. London: Academic Press; 2021. p. 23–45.
  • Miotto R, Wang F, Wang S, et al. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform. 2018;19(6):1236–1246. doi: 10.1093/bib/bbx044.